|
|
Kerstin Schwarzwaelder, Steven J. Howe, Manfred Schmidt, Martijn H. Brugman, Annette Deichmann, Hanno Glimm, Sonja Schmidt, Claudia Prinz, Manuela Wissler, Douglas J.S. King, Fang Zhang, Kathryn L. Parsley, Kimberly C. Gilmour, Joanna Sinclair, Jinhua Bayford, Rachel Peraj, Karin Pike-Overzet, Frank J.T. Staal, Dick de Ridder, Christine Kinnon, Ulrich Abel, Gerard Wagemaker, H. Bobby Gaspar, Adrian J. Thrasher, Christof von Kalle
J Clin Invest. 2007;
117(8):2241
doi:10.1172/JCI31661
Abstract |
Full text
| PDF
| Supplemental material

W
e treated 10 children with X-linked SCID (SCID-X1) using gammaretrovirus-mediated gene transfer. Those with sufficient follow-up were found to have recovered substantial immunity in the absence of any serious adverse events up to 5 years after treatment. To determine the influence of vector integration on lymphoid reconstitution, we compared retroviral integration sites (RISs) from peripheral blood CD3+ T lymphocytes of 5 patients taken between 9 and 30 months after transplantation with transduced CD34+ progenitor cells derived from 1 further patient and 1 healthy donor. Integration occurred preferentially in gene regions on either side of transcription start sites, was clustered, and correlated with the expression level in CD34+ progenitors during transduction. In contrast to those in CD34+ cells, RISs recovered from engrafted CD3+ T cells were significantly overrepresented within or near genes encoding proteins with kinase or transferase activity or involved in phosphorus metabolism. Although gross patterns of gene expression were unchanged in transduced cells, the divergence of RIS target frequency between transduced progenitor cells and post-thymic T lymphocytes indicates that vector integration influences cell survival, engraftment, or proliferation.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(77)
| Title and authors |
Publication |
Year |
Retroviral Integrations in Gene Therapy Trials
Luca Biasco, Cristina Baricordi, Alessandro Aiuti
|
Mol Ther
|
2012 |
Hematopoietic stem cell engineering at a crossroads
I. Riviere, C. E. Dunbar, M. Sadelain
|
Blood
|
2012 |
Methods in Enzymology
Eugenio Montini, Daniela Cesana
|
Gene Transfer Vectors for Clinical Application
|
2012 |
The β-Globin Locus Control Region in Combination With the EF1α Short Promoter Allows Enhanced Lentiviral Vector-mediated Erythroid Gene Expression With Conserved Multilineage Activity
Claudia A Montiel-Equihua, Lin Zhang, Sean Knight, Heba Saadeh, Simone Scholz, Marlene Carmo, Maria E Alonso-Ferrero, Michael P Blundell, Aiste Monkeviciute, Reiner Schulz
|
Mol Ther
|
2012 |
Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver
Ali Nowrouzi, Magalie Penaud-Budloo, Christine Kaeppel, Uwe Appelt, Caroline Le Guiner, Philippe Moullier, Christof von Kalle, Richard O Snyder, Manfred Schmidt
|
Mol Ther
|
2012 |
Ex vivo gene transfer and correction for cell-based therapies
Luigi Naldini
|
Nat Rev Genet
|
2011 |
Genotoxicity of retroviral hematopoietic stem cell gene therapy
Grant D Trobridge
|
Expert Opin. Biol. Ther.
|
2011 |
Klinische Anwendung der Gentherapie. Bisherige Erfahrungen und Zukunft
Barbara Langer, Klaus Cichutek
|
Pharmazie in unserer Zeit
|
2011 |
Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma
Douglas R. Kennedy, Brian J. Hartnett, Jeffrey S. Kennedy, William Vernau, Peter F. Moore, Thomas O’Malley, Linda C. Burkly, Paula S. Henthorn, Peter J. Felsburg
|
Veterinary Immunology and Immunopathology
|
2011 |
Creating Higher Titer Lentivirus with Caffeine
Brian L. Ellis, Patrick Ryan Potts, Matthew H. Porteus
|
Human Gene Therapy
|
2011 |
|